Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.24.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
12 Months Ended
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
CONDENSED CONSOLIDATED BALANCE SHEETS    
Marketable securities - amortized cost $ 2,940,000 $ 97,501,000
Marketable securities - Net of allowance for expected credit losses 0 0
Allowance for expected credit losses 0 0
Operating lease right-of-use assets, accumulated amortization 13,220,000 9,470,000
Property, plant and equipment, accumulated depreciation 46,020,000 38,588,000
Intangibles, accumulated amortization $ 5,155,000 $ 4,676,000
Common stock, shares authorized | shares 1,702,760,280 1,282,773,750
Common stock, shares issued | shares 1,363,008,102 987,109,890
Common stock, shares outstanding | shares 1,363,008,102 987,109,890